Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$616M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$239M |
| 3 |
DuPont de Nemours
DD
|
+$227M |
| 4 |
AbbVie
ABBV
|
+$223M |
| 5 |
General Motors
GM
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$299M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$284M |
| 3 |
RAI
Reynolds American Inc
RAI
|
+$229M |
| 4 |
BP
BP
|
+$216M |
| 5 |
Air Products & Chemicals
APD
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.84% |
| 2 | Energy | 10.94% |
| 3 | Miscellaneous | 8.86% |
| 4 | Technology | 8.76% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2751
Northeast Bank
NBN
$1.07B
| $162K | ﹤0.01% |
6,192
-1,284
| -17% | -$28K |
2016 Q4
3 quarters
|
|
2752
Greif
GEF
$4.64B
| $161K | ﹤0.01% |
2,751
-68
| -2% | -$3.88K |
2013 Q2
17 quarters
|
|
2753
Bassett Furniture
BSET
$165M
| $160K | ﹤0.01% |
4,270
-884
| -17% | -$32.7K |
2015 Q1
10 quarters
|
|
2754
Triumph Financial Inc
TFIN
$1.46B
| $160K | ﹤0.01% |
4,970
-1,030
| -17% | -$28.9K |
2015 Q3
8 quarters
|
|
|
OXFD
2755
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $160K | ﹤0.01% |
9,492
-1,966
| -17% | -$32K |
2016 Q3
4 quarters
|
|
|
AKAO
2756
DELISTED
Achaogen Inc
AKAO
| $160K | ﹤0.01% |
10,000
| – | – |
2016 Q4
3 quarters
|
|
|
TERP
2757
DELISTED
TerraForm Power, Inc
TERP
| $160K | ﹤0.01% |
12,128
| – | – |
2014 Q4
11 quarters
|
|
|
LGI
2758
Lazard Global Total Return & Income Fund
LGI
$222M
| $159K | ﹤0.01% |
9,485
+3,802
| +67% | +$62.9K |
2017 Q2
1 quarter
|
|
|
CHS
2759
DELISTED
Chicos FAS, Inc.
CHS
| $158K | ﹤0.01% |
17,652
-843
| -5% | -$7.17K |
2013 Q2
17 quarters
|
|
2760
Bank of Marin Bancorp
BMRC
$441M
| $157K | ﹤0.01% |
4,580
| – | – |
2016 Q1
6 quarters
|
|
2761
Piper Sandler
PIPR
$4.65B
| $157K | ﹤0.01% |
10,564
-364
| -3% | -$5.37K |
2013 Q2
17 quarters
|
|
2762
CALL
UnitedHealth
UNH
$328B
| $157K | ﹤0.01% |
+800
| New | +$155K |
2017 Q3
0 quarters
|
|
|
OREX
2763
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $157K | ﹤0.01% |
74,000
+5,500
| +8% | +$13.4K |
2017 Q1
2 quarters
|
|
|
OREX
2764
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $157K | ﹤0.01% |
74,000
+5,500
| +8% | +$13.4K |
2017 Q1
2 quarters
|
|
|
DHIL
2765
DELISTED
Diamond Hill
DHIL
| $156K | ﹤0.01% |
732
-124
| -14% | -$24.5K |
2015 Q2
9 quarters
|
|
2766
iShares US Utilities ETF
IDU
$1.33B
| $156K | ﹤0.01% |
2,348
-92
| -4% | -$6.19K |
2013 Q2
17 quarters
|
|
2767
NN Inc
NNBR
$300M
| $156K | ﹤0.01% |
5,346
-1,108
| -17% | -$30.1K |
2017 Q1
2 quarters
|
|
|
NAGE
2768
Niagen Bioscience
NAGE
$212M
| $156K | ﹤0.01% |
36,422
-7,546
| -17% | -$27.6K |
2017 Q2
1 quarter
|
|
|
BHVN
2769
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $156K | ﹤0.01% |
+4,182
| New | +$127K |
2017 Q3
0 quarters
|
|
2770
El Pollo Loco
LOCO
$432M
| $155K | ﹤0.01% |
12,740
-160,360
| -93% | -$1.97M |
2014 Q3
12 quarters
|
|
2771
Intellia Therapeutics
NTLA
$1.7B
| $155K | ﹤0.01% |
6,284
-1,638
| -21% | -$30.9K |
2016 Q3
4 quarters
|
|
|
TGI
2772
DELISTED
Triumph Group
TGI
| $155K | ﹤0.01% |
5,216
| – | – |
2013 Q2
17 quarters
|
|
2773
Trustmark
TRMK
$2.62B
| $155K | ﹤0.01% |
4,701
-113
| -2% | -$3.51K |
2013 Q2
17 quarters
|
|
2774
Smart Sand
SND
$219M
| $154K | ﹤0.01% |
22,668
+1,764
| +8% | +$11.3K |
2017 Q2
1 quarter
|
|
|
SINA
2775
DELISTED
Sina Corp
SINA
| $154K | ﹤0.01% |
1,343
-109
| -8% | -$11K |
2015 Q4
7 quarters
|
|
Similar funds
Bank of Montreal's Q3 2017 Portfolio in Review
As of Q3 2017, Bank of Montreal held 4,520 positions worth $109B, up 4.7% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of Montreal's Q3 2017 filing shows 258 new, 1,597 increased, 1,464 reduced and 295 closed positions. Its largest new stake was Kirkland Lake Gold Ltd Ordinary: 1,602,606 shares worth $20.7M. The largest sale was Mondelez International, an estimated $299M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Energy and Miscellaneous.
- Bank of Montreal's largest Q3 2017 buy was Kirkland Lake Gold Ltd Ordinary: 1,602,606 shares worth $20.7M.
- Bank of Montreal added most to Altaba Inc in Q3 2017, an estimated $616M increase.
- Bank of Montreal's biggest Q3 2017 reduction was Mondelez International, cutting an estimated $299M.
- Bank of Montreal fully exited Reynolds American Inc in Q3 2017, selling an estimated $229M.
- Bank of Montreal's ten largest holdings make up 21% of its $109B portfolio in Q3 2017.
- Bank of Montreal opened 258 new positions and closed 295 in Q3 2017.
- Bank of Montreal's portfolio value rose 4.7% quarter-over-quarter to $109B.
Based on Bank of Montreal's 13F filing for Q3 2017, filed 16 Oct 2017.